Browse Studies — Arctuva

An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

Background: STDG3 is an inherited eye disease. Currently there is no treatment for STDG3. Past studies of STDG3 have largely looked at members of large famili…

Stargardt-Like Macular Dystrophy

Estimated

~$10 – $675

National Eye Institute (NEI)NCT04591483

Phase 1

A Phase 1b, Open-label, Multicenter Dose-escalation Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Subretinal Dose of ASP2020 in Participants With Macular Dystrophies With a Stargardt-type Clinical Presentation

Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the …

Stargardt DiseaseStargardt Macular DystrophyStargardt-like Macular Dystrophy

Estimated

~$10 – $7,500

Astellas Institute for Regenerative MedicineNCT07734064

An Observational Study of Natural Disease Progression in Participants With Macular Dystrophies Expressing a Stargardt-type Clinical Presentation

Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the …

Stargardt DiseaseStargardt Macular DystrophyStargardt-like Macular Dystrophy

Estimated

~$10 – $1,050

Astellas Pharma Global Development, Inc.NCT07425574